Michael Young
Chairman bei BETTER CHOICE COMPANY INC.
Vermögen: 269 202 $ am 31.03.2024
Profil
Michael McGillivary Young is the founder of Cottingham Capital Ltd.
(founded in 2017) where he holds the title of Managing Director.
He is currently the Chairman at Better Choice Co., Inc. (since 2019) and a Director at Apolo IV Acquisition Corp.
(since 2021).
In his former positions, he served as Chairman at Origin Therapeutics Holdings, Inc., Director at Griffiths McBurney Corp.
(from 2003 to 2011), Managing Director at GMP Capital Corp.
(from 2016 to 2017), Managing Director at RF Capital Group, Inc. (from 2011 to 2016), Independent Director at ICC Labs, Inc. (from 2017 to 2018), Director at Nuuvera Holdings Ltd., Director at Aphria International, Inc. (from 2017 to 2018), Director at Apolo II Acquisition Corp., Director at Eve & Co., Inc. (in 2018), Director at XIB I Capital Corp., Director at Vice Health & Wellness, Inc., Non-Executive Independent Director at Yooma Wellness, Inc., and Trader at GMP Securities LP (from 2003 to 2010).
He also held the position of Chief Technology Officer at Thomson Reuters Corp.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.02.2024 | 42 367 ( 5,14% ) | 254 202 $ | 31.03.2024 | |
| 09.05.2023 | 500 000 ( 6,67% ) | 15 000 $ | 31.03.2024 |
Aktive Positionen von Michael Young
| Unternehmen | Position | Beginn |
|---|---|---|
| BETTER CHOICE COMPANY INC. | Chairman | 09.01.2020 |
| APOLO IV ACQUISITION CORP. | Director/Board Member | 20.01.2021 |
| Cottingham Capital Ltd. | Founder | 01.01.2017 |
Ehemalige bekannte Positionen von Michael Young
| Unternehmen | Position | Ende |
|---|---|---|
| SAFE SUPPLY STREAMING CO. LTD. | Chairman | 03.10.2022 |
| YOOMA WELLNESS INC. | Director/Board Member | 28.04.2021 |
| ICC LABS INC | Director/Board Member | 01.12.2018 |
| EVE & CO INCORPORATED | Director/Board Member | 01.10.2018 |
Aphria International, Inc.
 Aphria International, Inc. Pharmaceuticals: MajorHealth Technology Aphria International, Inc. engages in the development and production of medical cannabis products. It operates with partners in Germany, Israel and Italy, and is exploring opportunities in several other countries, to develop commercial production and global distribution of medical grade cannabis in legalized markets. The company is headquartered in Brampton, Canada. | Director/Board Member | 01.05.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| BETTER CHOICE COMPANY INC. | Retail Trade |
| THOMSON REUTERS CORPORATION | Technology Services |
| RF CAPITAL GROUP INC. | Finance |
| EVE & CO INCORPORATED | Health Technology |
| VICE HEALTH AND WELLNESS INC. | Distribution Services |
| YOOMA WELLNESS INC. | Distribution Services |
| Private Unternehmen | 11 |
|---|---|
Griffiths McBurney Corp.
 Griffiths McBurney Corp. Investment Banks/BrokersFinance Founded in 1995, Griffiths McBurney Corp. is a broker/dealer headquartered in Toronto, Ontario. The firm is a subsidiary of GMP Capital, Inc. (GMP: Toronto). They provide a full array of trading and execution services. Griffiths McBurney Corp. does not provide any internal research. All research is conducted through GMP Securities. | Finance |
GMP Securities LP
 GMP Securities LP Investment Banks/BrokersFinance Founded in 1995, GMP Securities LP is broker/dealer headquartered in Toronto with additional offices in Calgary and Montreal. The firm is a subsidiary of GMP Capital, Inc. (GMP: Toronto). They offer institutional sales, research, trading, investment banking and underwriting and advisory services. GMP Securities primarily focuses on the biotechnology, technology, mining, oil and gas, oil and gas income trusts, industrials, special situations and non-bank financial services sectors. | Finance |
| GMP Capital Corp. | Miscellaneous |
ICC Labs, Inc.
 ICC Labs, Inc. Agricultural Commodities/MillingProcess Industries ICC Labs, Inc. produces, develops and vendors recreational cannabis, medicinal cannabis and industrial hemp. It offers Agribusiness, Agroindustry, Cannabis, Hemp, CBD, Therpens, Cannabinoids, Hemp Oil, Hemp Fibre and Hemp Products. The company was founded in 2014 and is headquartered in Vancouver, Canada. | Process Industries |
Nuuvera Holdings Ltd.
 Nuuvera Holdings Ltd. Medical DistributorsDistribution Services Nuuvera Holdings Ltd. wholesales drugs. The firm focuses on building a global, chemical fee, pesticide free, vertically integrated business with an emphasis on principal elements: research & development of plant genetics, developing and maintaining proprietary control over plant genetics, cultivation of plant genetics, processing of harvested plant materials and marketing, sales & distribution. The company is headquartered in Toronto, Canada. | Distribution Services |
| Cottingham Capital Ltd. | |
Aphria International, Inc.
Aphria International, Inc. Pharmaceuticals: MajorHealth Technology Aphria International, Inc. engages in the development and production of medical cannabis products. It operates with partners in Germany, Israel and Italy, and is exploring opportunities in several other countries, to develop commercial production and global distribution of medical grade cannabis in legalized markets. The company is headquartered in Brampton, Canada. | Health Technology |
Apolo II Acquisition Corp.
 Apolo II Acquisition Corp. Financial ConglomeratesFinance Apolo II Acquisition Corp. is a capital pool company. It intends to identify and evaluate businesses or assets with a view to completing a qualifying transaction. The company was founded on December 15, 2017 and is headquartered in Toronto, Canada. | Finance |
XIB I Capital Corp.
 XIB I Capital Corp. Financial ConglomeratesFinance XIB I Capital Corp. engages in identification and evaluation of assets or businesses with a view to completing a Qualifying Transaction. The company was founded on March 8, 2018 and is headquartered in Vancouver, Canada. | Finance |
| Apolo IV Acquisition Corp. | |
Origin Therapeutics Holdings, Inc.
 Origin Therapeutics Holdings, Inc. Financial ConglomeratesFinance Origin Therapeutics Holdings, Inc. engages in the provision of investment services for psychedelic industry. It also plans to invest in opportunities involving, where legally permitted, the research, design, development, testing, production, distribution, and sale of psychedelics and services. The company was founded on December 9, 2020 and is headquartered in Vancouver, Canada. | Finance |
